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a b s t r a c t
Porcine reproductive and respiratory syndrome virus (PRRSV) represents a signiﬁcantly economical
challenge to the swine industry worldwide. In this study, we investigated the importance of cellular and
viral lipid rafts in PRRSV infection. First, we demonstrated that PRRSV glycoproteins, Gp3 and Gp4, were
associated with lipid rafts during viral entry, and disruption of cellular lipid rafts inhibited PRRSV entry.
We also showed the raft-location of CD163, which might contribute to the glycoproteins–raft association.
Subsequently, raft disruption caused a signiﬁcant reduction of viral RNA production. Moreover, Nsp9 was
shown to be distributed in rafts, suggesting that rafts probably serve as a platform for PRRSV replication.
Finally, we conﬁrmed that disassembly of rafts on the virus envelope may affect the integrity of PRRSV
particles and cause the leakage of viral proteins, which impaired PRRSV infectivity. These ﬁndings might
provide insights on our understanding of the mechanism of PRRSV infection.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Porcine reproductive and respiratory syndrome virus (PRRSV)
is an enveloped, single-strand positive-sense RNA virus belonging
to the family Arteriviridae, order Nidovirales (Collins et al., 1992;
Conzelmann et al., 1993; Wensvoort et al., 1991). Its genome is
approximately 15.4-kb containing a 50- and a 30-untranslated
region (UTR) and 10 open reading frames (Conzelmann et al.,
1993; Johnson et al., 2011; Meng et al., 1994; Meulenberg et al.,
1993). It encodes at least 16 non-structural proteins involved in
the processing of viral proteolysis, genome replication, transcrip-
tion and evading host immune responses, which include four
proteases (Nsp1α, Nsp1β, Nsp2, and Nsp4), the RNA-dependent
RNA polymerase (Nsp9), a helicase (Nsp10), and an endonuclease
(Nsp11) (Dokland, 2010; Fang et al., 2012; Snijder and Meulenberg,
1998; Ziebuhr et al., 2000). It also encodes eight structural
proteins including the membrane glycoproteins Gp2a, Gp2b,
Gp3, Gp4, Gp5, and Gp5a, the matrix protein (M), and the
nucleocapsid protein (N) involved in the process of viral entry,
assembling, and release (Dea et al., 2000; Johnson et al., 2011;
Meulenberg et al., 1995). These viral proteins are associated with
certain host factors to control the whole process of PRRSV
infection.
PRRSV has two major genotypes, the European genotype (type
1) and the North American genotype (type 2) (Forsberg, 2005;
Hanada et al., 2005). Recently, there have been devastating out-
breaks of atypical PRRS caused by a highly pathogenic PRRSV (HP-
PRRSV) strain in China, which is characterized by high fever, high
morbidity, and high mortality in all age pigs (Zhou and Yang,
2010). PRRSV has a very narrow cell tropism, showing a preference
for cells of the monocyte/macrophage lineage in vivo (Duan et al.,
1997). PRSSV is also sustained by MA-104 cell line derived from
African green monkey kidney and its derivatives (MARC-145 and
CL2621) in vitro (Kim et al., 1993). This cell tropism is mainly
determined by the presence or absence of speciﬁc receptors in the
target cells. PRRSV enters cells via receptor-mediated endocytosis,
and heparan sulfate, sialoadhesin, and CD163 are known as the
main PRRSV receptors (Van Breedam et al., 2010a). CD163, a
macrophage differentiation membrane antigen belonging to the
scavenger receptor cysteine-rich (SRCR) family, is shown to be
capable of mediating PRRSV infection in non-permissive cells
(Calvert et al., 2007).
The plasma membrane is proposed not to be a homogeneously
passive solvent, but a heterogeneous structure, displaying a
tremendous complexity of lipids and proteins (Lingwood and
Simons, 2010). The strong evidence for this theory is the presence
of lipid rafts that are specialized lipid domains enriched in
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sphingolipid, cholesterol, and a subclass of membrane proteins
(Munro, 2003; Simons and Ikonen, 1997). Rafts can incorporate or
exclude proteins selectively and coalesce into large domains to
form platforms that function in many cellular processes including
signal transduction, membrane trafﬁcking, cytoskeletal organiza-
tion, and pathogen infection (Brown and London, 2000; Simons
and Toomre, 2000). Since lipid rafts are rich in sphingolipid and
cholesterol, its resistance to cold detergent extraction has been
widely used as an index (Harder et al., 1998).
Lipid rafts are utilized in the lifecycle of numerous enveloped
viruses. Many enveloped viruses exploit lipid rafts for their entry
stages, in which the viral enveloped glycoproteins probably insert
into lipid rafts to interact with the raft-located receptors or
convert from their native state to activated form to initiate or
facilitate viral internalization and/or fusion (Ahn et al., 2002;
Bender et al., 2003; Popik et al., 2002). Lipid rafts are also found
in the intracellular structures and many special proteins such as
arrays of signal transduction proteins and some viral non-
structural proteins are found in lipid rafts on plasma membrane
and intracellular membranes, which contribute to efﬁcient traf-
ﬁcking, replication, assembly, and budding (Aizaki et al., 2004;
Barman and Nayak, 2007; Bhattacharya et al., 2006; Ono and
Freed, 2001). In addition, for certain viruses, the viral membrane
shows similar structure to lipid raft in cell membrane, and is
critical for their efﬁcient infections (Brugger et al., 2006; Graham
et al., 2003). Recently, it was reported that cholesterol-depletion
drugs could inhibit PRRSV infection and inﬂuence PRRSV entry to
Marc-145 cells (Huang et al., 2011). However, there is a lack of
detailed and direct evidence to prove whether lipid rafts function
in PRRSV entry process. Moreover, we still have little information
about whether lipid rafts are required in PRRSV infection and how
PRRSV utilizes lipid rafts. Here, we provide more evidence to verify
that PRRSV entry is associated with lipid rafts. In addition, we
show that lipid rafts in cell membrane play an important role in
PRRSV replication and release, and lipid rafts in PRRSV envelope
are also critical for its infection.
Result
Depletion of cellular cholesterol inhibits PRRSV infection
To assess whether PRRSV infection is sensitive to intact lipid
rafts, we tested the impact of Methyl-β-cyclodextrin (MβCD), a
drug widely used to sequester cholesterol (Ilangumaran and
Hoessli, 1998), on the infection of different PRRSV strains. Previous
studies have shown that upon treatment with MβCD membrane
cholesterol levels will remain low for 9–12 h (Li et al., 2007; Rojek
et al., 2008). Indeed, treatment with MβCD for 1 h effectively
reduced the level of cellular cholesterol in both Marc-145 cells and
PAMs by approximate 80–90% compared to that in untreated cells
at the concentration of 20 mM (Fig. 1A). Moreover, 2 h following
treatment with 30 mM MβCD, the Marc-145 cells or PAMs
retained relative viability of 100% compared with controls
(Fig. 1B), ruling out the possible nonspeciﬁc effects of cytotoxicity
caused by MβCD. Next, we treated Marc-145 cells with MβCD (0,
2.5, 5, 7.5, 10, and 20 mM) for 1 h prior to infection with PRRSV
strain CH1a (MOI¼1), and examined PRRSV infection using
indirect immunoﬂuorescent staining and quantiﬁed PRRSV titers
of the supernatant 24 h post infection. As shown in Fig. 1C and D,
CH1a infection was signiﬁcantly inhibited by MβCD in a dose-
dependent manner. And a titer-reduction of more than 104-fold
was observed at the concentration of 20 mM when compared with
the non-MβCD-treated cells (Fig. 1D). To investigate whether this
anti-PRRSV activity is strain speciﬁc, we did the same treatment
with PAMs and then infected it with HP-PRRSV strain Hpv
(MOI¼1). Our results showed that MβCD also inhibited Hpv
infection in PAMs, and a more than 1000-fold suppression was
observed at the concentration of 20 mM (Fig. 1E).
To conﬁrm that the inhibition of PRRSV infectivity is not due to
any nonspeciﬁc effect of MβCD, we performed a cholesterol
reconstitution experiment (Fig. 1F). Marc-145 cells were pre-
treated with 10 mM MβCD for 1 h, followed by addition of
cholesterol to replenish cells for 1 h. Cells were then infected with
CH1a (MOI¼1) and virus yield was analyzed 24 h post infection.
As expected, PRRSV infection was successfully restored by choles-
terol supplementation, conﬁrming that the inhibition by MβCD is
due to its speciﬁc sequestering of cholesterol. These results
indicated that cellular cholesterol depletion could inhibit PRRSV
infection, implicating that PRRSV infection might be associated
with cellular lipid rafts.
Cellular cholesterol depletion inhibits PRRSV entry but has no effect
on PRRSV binding
To further explore how lipid rafts inﬂuence PRRSV infection, we
ﬁrst determine whether the depletion of cellular cholesterol
affects PRRSV entry to the cells. The process of PRRSV entry
includes early attachment and subsequent internalization. To
address whether MβCD can inhibit PRRSV binding, Marc-145 cells
were pretreated with MβCD and then incubated with CH1a at 4 1C
(in this way, virions will bind to the cells without penetration). The
level of cell-bound viral RNA was analyzed. As shown in Fig. 2A,
the amount of bound virions was not affected even if a 20 mM
MβCD was used. PAMs treated as above also showed little
variation on their capability to bind Hpv virions (Fig. 2B). These
data suggest that cholesterol depletion has no effects on virus
attachment to the cells.
Previous studies have reported that PRRSV is completely inter-
nalized from the surface of Marc-145 cells within 3–6 h (Kreutz and
Ackermann, 1996; Nauwynck et al., 1999). To examine whether
cellular cholesterol depletion affects PRRSV internalization into
Marc-145 cells, cells were pretreated with MβCD and then incu-
bated with CH1a at 4 1C. Cells were subsequently shifted to 37 1C to
allow virus internalization for 3 h and the level of internalized viral
RNA in cells was analyzed (Fig. 2C). MβCD exhibited an obvious
dose-dependent inhibitory effect on CH1a in Marc-145 cells, show-
ing about 50% and 90.0% reductions of internalized PRRSV RNA in
cells treated with 5 mM and 20 mM MβCD compared to that in
untreated cells, respectively. A similar reduction was observed
when we did the same experiment with PAMs (Fig. 2D). We also
attempted to reverse the PRRSV entry by supplementing the cells
with exogenous cholesterol. Marc-145 cells were pretreated with
20 mM MβCD for 1 h, followed by addition of cholesterol to
replenish cells for 1 h. Then, cells were incubated with CH1a at
4 1C for 1 h and subsequently shifted to 37 1C to allow virus
internalization for 3 h. Then the level of internalized viral RNA in
cells was analyzed after non-internalized virions were washed
away. As expected, PRRSV entry was restored by cholesterol
supplementation in high concentration (Fig. 2E), conﬁrming that
the inhibition of PRRSV entry by MβCD is due to its speciﬁc
sequestering of cholesterol. These observations suggest that cellular
cholesterol depletion imposes an inhibition on the onset of PRRSV
infection.
Raft-distributed receptor CD163 might contribute to the association
of PRRSV glycoproteins with cellular lipid raft during entry
Our experimental datawith the cholesterol inhibitor MβCD suggest
that that lipid rafts might be associated with PRRSV entry. To provide
direct evidence for virion association with lipid rafts during PRRSV
entry, we infected PAMs with Hpv at 4 1C for 1 h. The cells were
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washed and subsequently shifted to 37 1C to initiate membrane fusion
and virion penetration. Cell lysates were harvested 2 h post the
temperature shift, and detergent-resistant membranes were isolated
by sucrose sedimentation as described in Materials and Methods. We
then performed immunoblot analysis with fractions using antibodies
that are reactive to individual viral envelope proteins (Gp3, Gp4, and
Gp5) (Fig. 3A). A moderate staining of Gp3 and Gp4 proteins was
present in the caveolin-rich raft-fraction, indicating that PRRSV Gp3
and Gp4 enveloped proteins were associated with lipid rafts during
entry. However, the protein Gp5 was almost excluded from the lipid
raft fractions and recovered in non-raft fractions associated with the
non-raft maker CD71 (Harder et al., 1998). However, when the PAMs
were pretreated with 20 mM MβCD for 1 h, we did not succeed in
isolating lipid raft and Gp3 and Gp4 were recovered in the fraction
with the non-raft protein CD71 (Fig. 3B), These results suggest that
lipid rafts might play a role in PRRSV entry.
It has been reported that CD163 is essential for internalization
and fusion, and a functional CD163 SRCR domain 5 can interact
with the Gp2 and Gp4 glycoproteins which form trimers with Gp3
(Van Gorp et al., 2010). Since the enveloped proteins of PRRSV
associated with lipid rafts on plasma membrane are Gp3 and Gp4
but not Gp5, we assume that CD163 might be located in lipid raft
microdomains. To verify this hypothesis, we also studied the
distribution of CD163 during PRRSV entry (Fig. 3A). As expected,
CD163 was found to be enriched in the raft-fractions, indicating
that CD163 may be a raft-located receptor. However, it is also
possible that binding of glycoproteins of PRRSV to rafts recruits
CD163 to these domains from non-raft components. Thus, we next
investigated whether CD163 was a raft-protein in uninfected cells.
We transfected CD163 into Hela cells and then treated cells with
20 mM MβCD for 1 h at 24 h post transfection. The CD163
distribution on MβCD-treated cell membrane was compared with
that of untreated cells using Immunoﬂuorescent assay. As shown
in Fig. 3C, CD163 proteins on untreated cellular membrane were
speckled while these spots disappeared and changed into a uni-
form distribution on cellular membrane upon MβCD treatment. To
Fig. 1. Cellular cholesterol depletion by MβCD induced a dose-dependent anti-PRRSV activity. (A) Cholesterol levels in Marc-145 cells and PAMs treated with MβCD. Cells
were treated with MβCD at the indicated concentrations for 1 h at 37 1C and then harvested for cholesterol analysis. (B) Cellular toxicity was examined in Marc-145 cells and
PAMs using MTT assay and was expressed as relative cell viability compared with the viable cells in the absence of MβCD (set up as 100%). (C and D) Anti-PRRSV activity of
MβCD was examined against the CH1a strain in Marc-145 cells. Marc-145 cells were pretreated with various concentrations of MβCD as described above and subsequently
infected with CH1a at an MOI of 1. The infected cells were measured by indirect immunoﬂuorescence assay for the N protein of PRRSV 24 h post-infection (C) and the virus
titers (TCID50) of supernatants were quantiﬁed (D). (E) MβCD treatment induced an antiviral activity against Hpv in PAMs. PAMs pretreated with MβCD were infected with
Hpv at an MOI of 1, and then the virus titers (TCID50) of supernatants were analyzed 24 h post infection. (F) Replenishment of cholesterol in cells rescues PRRSV infection.
Marc-145 cells were treated with 10 mM MβCD for 1 h, followed by replenishment with exogenous cholesterol at the indicated concentration for 1 h. Then the cells were
infected with CH1a at an MOI of 1 and the titers (TCID50) of supernatants were measured 24 h post infection. Cells without MβCD treatment and cholesterol replenishment
were set as a control. The data represent the mean7standard deviation from three independent experiments. Signiﬁcant differences compared with untreated group are
denoted by * (Po0.05), ** (Po0.01), and *** (Po0.001).
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further conﬁrm the CD163 location in uninfected PAMs, we
directly used sucrose gradients to isolate detergent-insoluble
fractions from PAMs and performed immunoblot to analyze
CD163 in fractions (Fig. 3D). A substantial portion of CD163 was
found to be restricted in the raft-fractions. These results suggest
that CD163 proteins are distributed in lipid rafts on cell membrane
in PAMs, which may mediate the association of PRRSV glycopro-
teins with rafts during viral entry.
Lipid raft plays an important role in PRRSV replication
RNA replication of virtually all positive-strand RNA viruses
requires certain intracellular membrane structures including endo-
plasmic reticulums (ER), Golgi apparatus and lysosomes (Restrepo-
Hartwig and Ahlquist, 1996; Shi et al., 1999; van der Meer et al.,
1999). Some of these viruses induce distinct membrane structural
scaffold to provide platforms for viral RNA replication, such as the
formation of lipid raft associated HCV RNA replication complex
(Aizaki et al., 2004; Gosert et al., 2002; Westaway et al., 1997).
Therefore, we attempted to investigate whether lipid rafts are
required for PRRSV RNA production. We infected PAMs with the
Hpv (MOI¼1) and then replaced the cell medium with fresh
medium containing 10 mM MβCD 12 h later. Viral RNA levels in
cells were quantitated using real-time PCR at 0, 6, and 12 h after
medium switching (Fig. 4A). Compared with the PBS-treated cells, a
signiﬁcant reduction of the intracellular viral RNA was observed
after MβCD treatment, suggesting that lipid rafts might be involved
in PRRSV replication. Next, we further examined the distribution of
Nsp9, the RNA dependent RNA polymerase of PRRSV after ﬂotation
analysis of PAMs which were infected with Hpv (MOI¼1) for 24 h
Fig. 2. Effect of cellular cholesterol depletion on PRRSV entry. (A and B) MβCD pretreatment of cells did not affect PRRSV binding. Marc-145 cells or PAMs were pretreated
with MβCD at the indicated concentrations for 1 h at 37 1C and then incubated with CH1a (A) and Hpv (B) virions, respectively, at an MOI of 5 at 4 1C for 1 h. Unbound virus
particles were removed, and the cell-associated PRRSV ORF7 RNA level was analyzed using real-time RT-PCR. (C and D) MβCD pretreatment of cells inhibited viral
internalization of PRRSV. Marc-145 cells or PAMs were pretreated with MβCD at the indicated concentrations for 1 h at 37 1C prior to incubation with CH1a (C) and Hpv
(D) virions at an MOI of 5 at 4 1C for 1 h. Cells were then switched to 37 1C for 3 h, followed by removal of noninternalized virions. The internalized PRRSV ORF7 RNA level in
cells was analyzed using real-time RT-PCR. (E) Replenishment of cholesterol in cells rescues PRRSV entry. Marc-145 cells were treated with 20 mMMβCD for 1 h, followed by
replenishment with exogenous cholesterol at the indicated concentration for 1 h. Then the cells were incubated with CH1a (MOI¼5) and the internalized viral RNA level in
cells was analyzed using real-time PCR. Cells without MβCD treatment and cholesterol replenishment were set as a control. The data represent the mean7standard
deviation from three independent experiments. Signiﬁcant differences compared with untreated group are denoted by * (Po0.05), ** (Po0.01), and *** (Po0.001).
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(Fig. 4B). Signiﬁcantly, a substantial portion of Nsp9 was in the
fraction referred to be as the lipid raft. However, when these
infected PAMs were treated with 20 mM MβCD for 1 h, little lipid
rafts were isolated and Nsp9 were co-recovered with CD71 (Fig. 4C).
These results suggest that PRRSV RNA synthesis may occur in lipid
raft membrane microdomains.
Lipid raft disruption by cholesterol depletion enhances the production
of abnormal PRRSV particles
Lipid rafts have been reported to be implicated in the release of
a wide variety of viruses, including human immunodeﬁciency
(HIV), Newcastle disease virus (NDV) and inﬂuenza (Barman and
Nayak, 2007; Laliberte et al., 2006; Nguyen and Hildreth, 2000).
Thus, we attempted to investigate the effect of cholesterol deple-
tion by MβCD treatment on PRRSV release. Marc-145 cells and
PAMs were infected with CH1a and Hpv for 24 h, respectively, and
then medium was replaced with fresh medium containing MβCD
(0, 10, and 20 mM). At 1 h later, the amount of virus released into
the medium was quantiﬁed by analysis of PRRSV envelope protein
Gp5 (Fig. 5A). Our results showed that the Gp5 release was
enhanced with the increasing concentration of MβCD treatment.
However, the RNA level and titer of the released virus particles had
no obvious difference when treated with either 10 mM or 20 mM
MβCD compared to that of the no-treatment control (Fig. 5B and
C). It is possible that MβCD-treatment causes the release of more
Fig. 3. Distribution of certain glycoproteins on the cellular lipid raft during PRRSV entry and lipid raft-location of receptor CD163. (A) The distribution of Gp3, Gp4, Gp5, and
CD163 in the different sucrose gradient fractions during entry. PAMs were incubated with Hpv at an MOI of 5 at 4 1C for 1 h and then switched to 37 1C for 2 h. Cells were
extracted in Triton X-100 and fractionated by discontinuous sucrose gradient centrifugation as described in Materials and Methods. The fractions were separated by SDS-12%
PAGE and transferred to PVDF membranes for immunoblot analysis for nonraft marker CD71, raft maker caveolin (Cav), Gp3, Gp4, Gp5, or CD163. (B) The distribution of Gp3,
Gp4, Gp5, and CD163 in different sucrose gradient fractions during PRRSV entry upon MβCD pretreatment. PAMs were pretreated with 20 mM MβCD for 1 h and then
incubated with Hpv at an MOI of 5 at 4 1C for 1 h and then switched to 37 1C for 2 h. Cells were extracted in Triton X-100 and fractionated by discontinuous sucrose gradient
centrifugation as described in Materials and Methods. The fractions were separated by SDS-12% PAGE and transferred to PVDF membranes for immunoblot analysis for CD71,
Cav, Gp3, Gp4, Gp5, or CD163. (C) MβCD treatment affected the distribution of CD163. Hela cells were transfected with plasmid encoding CD163 and treated with 20 mM
MβCD at 37 1C for 1 h at 24 h post transfection. The cells treated with PBS were set as a control. The expression of CD163 on cell membrane was stained by indirect
immunoﬂuorescence assay after MβCD treatment. (D) Association of CD163 with lipid rafts. PAMs were extracted in Triton X-100 and fractionated on sucrose gradients.
Proteins were resolved on SDS-PAGE and transferred to PVDF membrane for immunoblot analysis of CD163, Cav, and CD71.
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immature viral particles from infected cells compared with that in
untreated infected cells. There is also a possibility that MβCD-
treatment changed the virion components of the released PRRSV
particles.
Depletion of cholesterol from the viral envelope impairs PRRSV
infection
To clarify whether cholesterol elimination of virions affects
PRRSV infectivity, we depleted cholesterol of CH1a and Hpv virions
by MβCD treatment prior to infection. Puriﬁed PRRSV were treated
with 0, 10, 20, 30, 50, or 80 mM MβCD for 1 h at 37 1C, and then
the drug was removed by ultracentrifugation as described in
Materials and Methods. The residual cholesterol content in viral
preparations was measured after MβCD treatment. As shown in
Fig. 6A, both the envelopes of CH1a and Hpv virions contained a
certain amount of cholesterol and a remarkable dose-dependent
decline was observed after MβCD treatment (approximately 90.0%
at 80 mM MβCD). Then, we used MβCD-treated CH1a virions to
infect Marc-145 cells and examined the infected cells using an
indirect immunoﬂuorescent assay 24 h post infection. As shown in
Fig. 6B, a signiﬁcant dose-dependent reduction was observed for
the number of infected cells. We also analyzed the direct effects of
MβCD treatment on the titers of CH1a and Hpv virions. MβCD
induced a signiﬁcant dose-dependent titer-reduction for CH1a,
and a more than 106-fold reduction was observed at the concen-
tration of 80 mM compared with the untreated virus (Fig. 6C).
Similarly, MβCD treatment induced a more than 104-fold reduc-
tion for the titer of Hpv at the concentration of 80 mM when
compared with the untreated virus (Fig. 6D).
To further verify that the decrease in PRRSV infectivity is
caused by cholesterol depletion in the virus envelope, we
attempted to reverse the infectivity by supplementing virions
with exogenous cholesterol. After extraction of viral cholesterol
in CH1a by 20 mM MβCD for 1 h, virus was supplemented with
exogenous cholesterol (0, 50, 100, 200, and 500 μM) for 30 min at
37 1C, and then the titer of the virus was tested. The infectivity of
MβCD-treated virus particles was recovered upon cholesterol
replenishment in a dose-dependent manner, even though it was
not completely restored up to 500 μM cholesterol (Fig. 6E). These
data suggest that the effect of MβCD on PRRSV infectivity is mainly
due to the reduced cholesterol levels in the virus envelope and the
Fig. 4. Association of lipid raft with PRRSV replication. (A) The effect of PRRSV
replication at the indicated time intervals in PAMs upon MβCD treatment. PAMs
were infected with Hpv at an MOI of 1 for 12 h (represented as 0 h on graph), and
then the medium was replaced with fresh medium containing 10 mM MβCD. ORF7
RNA level in cells was analyzed using real-time RT-PCR at 0, 6, and 12 h after
treatment. Data shown as mean7standard deviation from three independent
experiments. Signiﬁcant differences compared with 0 h group are denoted by *
(Po0.05) and ** (Po0.01). (B) Association of Nsp9 with raft. PAMs were harvested
24 h after infection with Hpv at an MOI of 1. Cells were extracted in Triton X-100
and fractionated by discontinuous sucrose gradient centrifugation as described in
Materials and Methods. Each fraction was resolved on SDS-PAGE and transferred to
PVDF membrane for immunoblot analysis of Nsp9, Cav, and CD71. (C) PAMs were
harvested 24 h after infection with Hpv at an MOI of 1. Cells were treated with
20 mM MβCD for 1 h and then extracted in Triton X-100 and fractionated by
discontinuous sucrose gradient centrifugation as described in Materials and
Methods. Each fraction was resolved on SDS-PAGE and transferred to PVDF
membrane for immunoblot analysis of Nsp9, Cav, and CD71.
Fig. 5. Effect of MβCD treatment on virus release. (A) Virus particles released from
MβCD-treated cells. Marc-145 cells or PAMs were infected with CH1a or Hpv at an
MOI of 1. At 24 h post infection, the medium was replaced with fresh medium
containing 0, 10, or 20 mM MβCD to treat cells for 1 h. The released virus particles
in supernatant were harvested and viral proteins were separated in SDS-PAGE and
transferred to PVDF membrane for immunoblot analysis of Gp5. (B) Viral RNA of
viruses released from the infected cells after MβCD treatment was quantiﬁed by
real-time RT-PCR. (C) Titers (TCID50) of viruses released from the infected cells after
MβCD treatment were quantiﬁed. Data shown as mean7standard deviation from
three independent experiments.
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infection of PRRSV to target cells is dependent on the integrity of
the lipid raft in the virus envelope.
Depletion of cholesterol from the PRRSV envelope results in
permeabilization of virions
Since our data show that the cholesterol reduction in viral
envelope can inhibit PRRSV infectivity, it is possible that viral lipid
raft disruption induced by cholesterol removal disrupts PRRSV
virus particles. To extend our understanding of this effect, puriﬁed
CH1a virions were treated with 0, 10, 20, 30, 50, or 80 mM MβCD
for 1 h at 37 1C and re-puriﬁed by ultracentrifugation as described
in Materials and Methods. Western blotting was then performed
to determine whether MβCD treatment has effects on viral
envelope protein (Gp5) or Nucleocapsid protein (N protein). As
shown in Fig. 7A, the amount of N protein exhibited a dose-
dependent reduction induced by MβCD treatment, while the
amount of Gp5 was fairly constant up to 80 mM MβCD. The
permeabilization was deﬁned as a greater decrease of the capsid
protein relative to the envelope glycoprotein. Thus, depletion of
cholesterol from viral envelope resulted in permeabilization of
PRRSV virions. We also tested the viral RNA levels of the MβCD-
treated CH1a virions to determine whether viral RNA is retained in
PRRSV virions (Fig. 7B). Our results showed little change in the
amount of viral RNA in CH1a virions after MβCD treatment,
suggesting that PRRSV particles do not lose viral RNA after
permeabilization by MβCD. These results reveal that depletion of
Fig. 6. Requirement of cholesterol in the viral envelope for efﬁcient PRRSV infection. Puriﬁed virus was treated with 0, 10, 20, 30, 50, and 80 mM MβCD for 1 h at 37 1C and
then re-collected as described in Materials and Methods. (A) Residual cholesterol in virions following MβCD treatment was quantitated. (B) Cholesterol depletion of virus
inhibited PRRSV infection in Marc-145 cells. Marc-145 cells were incubated with MβCD-treated CH1a virions as above. The infected cells were stained by indirect
immunoﬂuorescence assay for the PRRSV N protein 24 h post-infection. (C and D) The titers (TCID50) of CH1a (C) and Hpv (D) treated with various concentrations of MβCD as
above were quantiﬁed. (E) Infection efﬁciency of cholesterol-depleted PRRSV after replenishment with exogenous cholesterol. CH1a virions were cholesterol depleted by
treatment with 20 mMMβCD at 37 1C for 1 h. Prior to infection in Marc-145 cells, virions were replenished by increasing concentrations of exogenous cholesterol at 37 1C for
30 min. Infection efﬁciencies were determined by analysis of the viral titer (TCID50). The data represent the mean7standard deviation from three independent experiments.
Signiﬁcant differences compared with untreated group are denoted by * (Po0.05), ** (Po0.01), and *** (Po0.001).
Fig. 7. Effect of PRRSV particles with MβCD treatment. (A) Treatment of PRRSV with
increasing concentrations of MβCD resulted in permeabilization of the viral
membrane and loss of capsid protein. CH1a virions were treated with MβCD at
the indicated concentration for 1 h at 37 1C and re-collected. Samples were
analyzed by SDS-PAGE and transferred to PVDF membrane for immunoblot analysis
of Gp5 and N protein. (B) Viral RNA retained upon permeabilization induced by
MβCD treatment. Virus prepared as above was analyzed for particle-associated viral
RNA by real-time RT-PCR. Virus input was normalized to Gp5 content.
Q. Yang et al. / Virology 484 (2015) 170–180176
viral cholesterol may impair PRRSV infectivity due to the virion
disruption and leak of nucleocapsid protein.
Discussion
Lipid rafts exist in cell plasma membranes, intracellular orga-
nelles and viral envelopes, which are different in their composi-
tion, physical properties, and biological functions (Brown and
London, 1998; Chazal and Gerlier, 2003; Ikonen, 2001). The
signiﬁcance of lipid rafts in either the viral envelope or the target
cell membrane has been demonstrated for many viruses. Here, we
investigated the importance of lipid rafts in viral envelope and
cellular membranes for PRRSV infection.
Our work showed that cellular cholesterol was important in
establishing PRRSV infection both in Marc-145 cells and PAMs. By
incubating cells with cholesterol-depletion drug before virus
infection, only cellular cholesterol will be removed, allowing viral
cholesterol and infectivity to remain intact. Under such condition,
the efﬁciency of infection is dependent on the amount of choles-
terol residual on cell membrane. Direct replenishment of exogen-
ous cholesterol to cells after drug-mediated cholesterol depletion
substantially restored PRRSV infection. These data indicate that
the efﬁciency of PRRSV infection at least in part is associated with
the cholesterol level on cell membranes.
Molecular simulations of model membranes show that the
integrity of lipid raft microdomains is sensitive to minor changes
of cholesterol (Risselada and Marrink, 2008). Thus, cholesterol is a
major component of lipid raft microdomains, and manipulation of
cholesterol present within membranes is frequently used to
implicate lipid rafts. Therefore, we further investigated whether
and how PRRSV infection was affected by cellular lipid rafts. PRRSV
entry process is mediated by receptor-speciﬁc endocytosis, where
the virus attachment, internalization and membrane fusion occur
sequentially (Nauwynck et al., 1999). Previous study has reported
the signiﬁcant suppression of cellular cholesterol depletion on
PRRSV entry, which is in consistent with our results (Sun et al.,
2011). These results are similar to the ﬁndings observed on some
other members of the order Nidovirales such as HCoV-229E, MHV
and SARS-CoV (Choi et al., 2005; Li et al., 2007; Nomura et al.,
2004; Thorp and Gallagher, 2004). However, how lipid rafts
contribute to PRRSV entry is not explicit, Although it has been
reported that Gp4 is located in lipid rafts when it is exogenously
expressed in HeLa cells and that Gp4 and CD163 co-located in lipid
rafts in a porcine kidney cell line (Du et al., 2012), there is no direct
and convincing evidence to show the association of Gp4, CD163,
and other glycoproteins with lipid rafts in PAMs during PRRSV
entry. By the use of Triton X-100 extract and discontinuous sucrose
gradient fractionation, we showed that the viral envelope proteins
Gp3 and Gp4, but not Gp5, were partitioned in lipid rafts during
virus penetration of PAMs. These results correspond well with
their roles in PRRSV entry. Gp5 interacts with the sialoadhesin
receptor to mediate virus-cell binding and initial endocytosis (Van
Breedam et al., 2010b), while Gp3 and Gp4, which form trimers
with Gp2, interacting with CD163 are essential for the following
internalization and fusion (Van Gorp et al., 2010). These data imply
that lipid rafts probably utilize cellular receptor CD163 to mediate
its association with PRRSV envelope proteins during entry. Con-
sistent with this assumption, we showed that CD163 was mainly
located in lipid raft microdomain of PAM membrane, and the
distribution of the CD163 on cell membrane was found to be
altered by cholesterol depletion. Moreover, PRRSV enters cells by a
process of clathrin-mediated endocytosis which is distinguished
from lipid raft-mediated endocytosis pathway (Kreutz and
Ackermann, 1996; Mercer et al., 2010; Nauwynck et al., 1999).
Therefore, we infer that lipid rafts probably contribute to
membrane fusion but not endocytosis in PRRSV entry. The glyco-
proteins–receptor interaction may trigger the raft clustering to
form platforms, which may function in PRRSV membrane fusion.
Viral RNA replication is a multistep process involving a replica-
tion complex that is formed by viral and cellular components with
the viral genomic RNA template. This replication complex is
embedded within particular virus-induced membrane vesicles,
which serve as the anchoring sites for the PRRSV replication
complex to mediate migration of the replication complex between
cellular organelles (Bost et al., 2003; den Boon and Ahlquist, 2010;
Netherton and Wileman, 2011). In the present study, a signiﬁcant
reduction of the intracellular viral RNA resulted from cholesterol
depletion, indicating that lipid rafts are probably involved in
PRRSV RNA production. PRRSV replication is directed by at least
14 replicase proteins that have both common enzymatic activities,
especially the viral RNA-dependent RNA polymerase Nsp9 (Fang
and Snijder, 2010; Yun and Lee, 2013). Flotation analysis of
infected PAMs showed that Nsp9 was distributed in lipid raft
fractions. Thus, lipid rafts might serve as the sites for viral RNA
replication complex anchored to PRRSV-induced special mem-
brane structural scaffold. However, the precise mechanism for this
association of special membrane structure with viral replication
complex remains to be determined. Membrane lipid rafts have
been implicated in the assembly and release of many enveloped
viruses. Our results also showed that lipid raft disruption
increased the release of PRRSV particles. For some virus such as
inﬂuenza virus, lipid rafts and their underlying cortical cytoskele-
ton probably provide a framework for speciﬁc and ordered viral
protein-protein interactions required for proper assembly (Roberts
and Compans, 1998; Simpson-Holley et al., 2002). Cholesterol
depletion could induce rearrangement of the cortical actin cytos-
keleton in many cells and cortical actin rearrangements also could
induce reorganization of lipid raft microdomains (Chadda et al.,
2007; Francis et al., 1999; Simpson-Holley et al., 2002). Therefore,
perturbation of actin cytoskeleton caused by cholesterol depletion
might contribute to the enhanced release of PRRSV particles
envelope proteins. However, no increase in viral RNA level or
virus infectivity was observed for the PRRSV particles released
from lipid raft disrupted cells. It is possible that lipid raft disrup-
tion might induce abnormal assembly and release of PRRSV
particles.
Cholesterol depletion may also mediate disruption of PRRSV
particles and directly cause the reduction in viral infectivity. PRRSV
virions contain a certain amount of cholesterol and this lipid feature
seems to be critical in sustaining its integrity. Our results showed that
both CH1a and Hpv infectivity was decreased in a dose-dependent
manner when the viruses were treated with cholesterol-depletion
drug. Measuring the residual cholesterol in PRRSV virions exposed to
increasing concentrations of MβCD indicated that the loss of infectivity
was closely associated with reduction in virion cholesterol. The loss of
viral infectivity after cholesterol depletion is likely due to partly
structure destruction such as loss of viral structure proteins or loss
of viral RNA. Indeed, PRRSV viral envelopes were permeabilized when
treated with MβCD at a high concentration, evidenced by the loss of
PRRSV nucleoprotein (N). Accordingly, we were unable to completely
restore virus infectivity by adding back cholesterol to permeabilized
virions. Presumably, even though the large holes in the viral mem-
brane can be repaired by cholesterol, patching themembrane probably
cannot overcome the loss of critical viral proteins. Recent cryo-electron
tomographic structure determination of PRRSV has provided a possi-
ble model for the nucleocapsid–RNA organization in the virion. This
model speculates that two layers of N dimers form a linked, twisted
chain with the RNA in the middle, and this chain is then bundled into
a roughly spherical shape that leaves a hollow interior (Dokland, 2010;
Spilman et al., 2009). The disordered appearance of the PRRSV core
may suggest a more loosely organized nucleocapsid which makes it
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easier for the N protein to leak upon MβCD treatment. However, the
permeabilization of PRRSV virions may not be enough to result in the
loss of the entire genome. Therefore, disassembly of lipid rafts on the
virus envelope affected integrity of viral envelope and caused the viral
envelope leakage of viral proteins to adversely affect virus infectivity.
In summary, our results have shown that PRRSV infection
depends on the presence of lipid rafts in both cellular membrane
and viral envelope. Cellular lipid rafts play an essential role in
PRRSV entry, replication and release, and viral lipid raft structures
are required to maintain virion core integrity to ensure PRRSV
infectivity. These ﬁndings promote us to further investigate how
viral proteins are associated with lipid rafts and how lipid raft
domains function in the organization of a mature PRRSV particle
production. Also, the perturbation of membrane lipid rafts by
small molecules to interfere with PRRSV infection could provide a
means for development of antiviral agents.
Materials and methods
Cells and viruses
Marc-145 cells and Hela cells were maintained in Dulbecco's
minimum essential medium (DMEM) supplemented with 10% FBS.
Porcine alveolar macrophages (PAMs) were obtained from post-
mortem lung lavage of 8-week-old speciﬁc pathogen free (SPF)
pigs, and maintained in RPMI 1640 medium with 10% FBS. All the
cells were cultured and maintained at 37 1C with 5% CO2. PRRSV
strains, CH1a (a type 2 PRRSV strain isolated in China) and Hpv (a
highly pathogenic PRRSV (HP-PRRSV) isolate), were propagated
and titrated in Marc-145 cells and PAMs. Brieﬂy, PRRSV was
serially diluted 10-fold in complete DMEM or RPMI 1640 to infect
5104 Marc-145 cells or PAMs in 96-well plates. PRRSV infection
was determined 48 h post infection using immunoﬂuorescent
staining for the PRRSV N protein. The viral titer was determined
by the Reed-Muench method and expressed as tissue culture
infective dose 50% (TCID50).
Antibodies and reagents
Methyl-β-cyclodextrin (MβCD) was from Sigma-Aldrich. Anti-
body against caveolin-1 was purchased from Cell Signaling Tech-
nology. Anti-CD71 antibody was purchased from Acris Antibodies
GmbH. Anti-PRRSV N protein monoclonal antibody was purchased
from Rural Technologies. Anti-Gp3 antibody was a gift from Dr.
Zhi-jun Tian (Harbin Veterinary Research Institute, CAAS, China).
The antisera for Gp4, Gp5, and Nsp9 were prepared by our lab.
Antibody against CD163 was purchased from AbD Serotec Com-
pany. Goat anti-mouse or anti-rabbit IgG secondary antibodies
were also purchased from Santa Cruz. Goat anti-porcine IgG
secondary antibody was purchased from Bethyl Laboratories.
Rabbit anti-goat IgG secondary antibody was purchased from
EASYBIO Company.
Plasmid
The cDNA encoding porcine CD163 was ampliﬁed using reverse
transcription-PCR (RT-PCR) from total RNAs extracted from por-
cine alveolar macrophages (PAMs) and cloned into pcDNA3.1.
Cholesterol measurement
Cholesterol was measured using an Amplex Red cholesterol
assay kit (Molecular Probes, Eugene, Oreg.) following the manu-
facturer's introduction.
Cell viability assay
Cytotoxic effects of MβCD were evaluated by the MTT (3-(4,5)-
dimethylthiahiazo(-z-y1)-3,5-di-phenytetrazolimromide) assay.
Marc-145 cells or PAMs in a 96-well plate were cultured in
100 μl DMEM or RPMI 1640 containing 0, 2, 4, 6, 8, 10, 15, 20, or
30 mM MβCD for 2 h at 37 1C. Next, the culture medium was
replaced with fresh medium containing 20 μl of 5 mg/ml MTT
after washing three times with PBS, and cells were further
cultured for 4 h at 37 1C. Cells were then washed carefully and
150 μl DMSO was added per well to dissolve the crystals for
10 min. The resulting absorbance of each well was recorded at
490 nm using a plate reader.
Indirect immunoﬂuorescent assay
Cells were ﬁxed with methanol–acetone solution (1:1) for
10 min at 4 1C, and then were blocked with 5% goat serum in
PBS for 30 min at 37 1C. PRRSV N protein or CD163 was detected
using corresponding speciﬁc monoclonal antibody, MAb SDOW17
(1:10,000; Rural Technologies) or MAb MCA2311 (1:5000; AbD
Serotec), and the secondary goat anti-mouse IgG (HþL) conju-
gated with FITC (1:200, Jackson ImmunoResearch). Nuclei were
stained with 4, 6-diamidino-2-phenylindole (DAPI). Immunoﬂuor-
escence was observed using Leica Microsystems CMS GmbH.
PRRSV binding and internalization assay
For binding assay, Marc-145 cells or PAMs were pretreated with
MβCD (0, 5, 10, 15, and 20 mM) for 1 h and then incubated with
CH1a (MOI¼5) or Hpv (MOI¼5) at 4 1C for 1 h. Then, the unbound
viruses in supernatants were removed and the level of cell-bound
viral RNA was analyzed by real-time PCR. For entry assay, Marc-
145 cells or PAMs were pretreated with MβCD (0, 5, 10, 15, and
20 mM) for 1 h and then incubated with CH1a (MOI¼5) or Hpv
(MOI¼5) at 4 1C for 1 h. The inoculums were replaced with fresh
culture medium to eliminate the unbound virus particles and cells
were subsequently shifted to 37 1C to allow virus internalization
for 3 h. Then cells were carefully washed with phosphate buffered
saline (PBS) three times to remove the noninternalized virions and
the level of viral RNA in cells was analyzed using real-time PCR.
Quantitation of viral RNA
The RNA of puriﬁed virus was extracted with the viral RNA kit
(OMEGA). Total RNA from Marc-145 cells or PAMs was extracted
using the TRIzol reagent. RNAs were converted to cDNA using
Superscript III Reverse Transcriptase (Invitrogen). For the quanti-
ﬁcation of puriﬁed virus, PRRSV RNA was analyzed using quanti-
tative real-time RT-PCR with primers designed against PRRSV
ORF7 (Patel et al., 2008). A plasmid containing ORF7 sequence
was used to generate a standard curve, and RNA copies in all
samples were calculated based on it (Han et al., 2009). The
transcript levels of cell-associated viral RNA were relatively quan-
tiﬁed by the 2-ΔΔCT Method (Livak and Schmittgen, 2001).
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA was
set as a control.
Lipid raft isolation
Low-density detergent-insoluble lipid raft fractions were iso-
lated as described previously with modiﬁcations (Chung et al.,
2005). Brieﬂy, PAMs were scraped with a rubber policeman into
ice-cold PBS and collected by centrifugation at 1000g for 3 min at
4 1C. Then pelleted cells were lysed using 0.3 ml of ice-cold TNE
buffer (25 mM Tris [pH 7.5], 150 mM NaCl, 5 mM EDTA) containing
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1% Triton X-100 (Merck), 1 mM NaF, and a cocktail of protease
inhibitors (Thermo) at 4 1C for 30 min with gentle agitation. Then,
the cell lysates were centrifuged at 4 1C for 10 min at 3500g to
remove nuclei and insoluble materials. The supernatants were
collected and mixed with equal volumes of 80% (wt/vol) sucrose in
TNE buffer and then placed in the bottoms of ultracentrifuge tubes.
A discontinuous sucrose gradient was formed by sequentially
overlaying 2.1 ml of 30% and 1.2 ml of 5% sucrose in TNE buffer.
These mixtures were centrifuged at 4 1C for 18 h at 250,000g in a
SW 55 Ti rotor (Beckman). After centrifugation, lipid rafts could be
visible as an opaque band at the boundary between the 5% and
30% sucrose solutions. A total of 11 gradient fractions were
collected from the top to bottom and stored at 80 1C until use.
Puriﬁcation of virus and preparation of MβCD-treated virus
Culture supernatants were clariﬁed by centrifugation at 2500g
for 5 min and then viruses were isolated from clariﬁed cell culture
supernatants subjected to sedimentation through 20% sucrose (wt/
vol) to 65% sucrose interface by centrifuging at 4 1C for 10 h at
100,000g in a SW50.1 rotor (Beckman). After virion ﬂotation,
puriﬁed virus was taken from 20% to 65% sucrose interface
fractions and stored at 80 1C until use.
MβCD-treated virus was prepared by incubating virus in the
presence of the indicated concentration of MβCD for 1 h at 37 1C
with gentle mixing. Virus was then re-puriﬁed by ultracentrifuga-
tion at 4 1C for 2 h at 200,000g in a SW 55 Ti rotor (Beckman). The
resulting pellet obtained for each treatment condition was re-
suspended to the same volume of PBS. Treated and concentrated
virus was divided into aliquots in small volumes and stored at
80 1C until use.
Western blot analysis
Similar amount of volume from each sample was resolved by
SDS-PAGE and transferred to polyvinylidene diﬂuoride (PVDF)
membranes (Millipore). Membranes were blocked with 5% nonfat
milk in phosphate-buffered saline with 0.05% Tween 20 (PBST)
and incubated for 2 h at room temperature with the primary
antibodies at a suitable dilution (anti-Gp3 and –Gp4 at 1:200, anti-
CD71 at 1:500, anti-caveolin at 1:1000, anti-N protein at 1:2000,
anti-Nsp9 at 1:3000, and anti-Gp5 and –CD163 at 1:5000). The
membranes were washed by PBST and then incubated with the
appropriate secondary antibody for 1 h at a dilution of 1:10,000.
The membranes were washed by PBST again and the antibodies
were visualized by use of the enhanced chemiluminescence (ECL)
reagent according to the manufacturer's instructions.
Statistical analysis
All experiments were performed with at least three indepen-
dent replicates. Results were analyzed by GraphPad Prism soft-
ware using Student's t test. Po0.05 was considered to be
statistically signiﬁcant.
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